Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Editorial

Novel and Practical Approaches to Manage Diet-induced Metabolic Disorders: Part-I

Author(s): Mallikarjuna Korivi and Betty Revon Liu

Volume 26, Issue 39, 2020

Page: [4953 - 4954] Pages: 2

DOI: 10.2174/138161282639201110165712

Abstract

Metabolic syndrome (MetS) which is caused by poor dietary habits and sedentary behavior is a serious global health problem. MetS is a cluster of risk factors, represented by central obesity, hyperglycemia, dyslipidemia, and hypertension. In the 21st century, MetS and associated comorbidities, including obesity, diabetes and cardiovascular diseases, are the major threats to human health. Practical dietary strategies, nutritional bioactive compounds and a healthy lifestyle are claimed to be efficient in the management of one or more components of MetS. Nevertheless successful management of MetS and commodities is still a major concern. Since hyperglycemia, inflammation and redox imbalance are intrinsically involved in the progression of MetS comorbidities, finding effective strategies that precisely target these systems is highly warranted. In this scenario, pharmacological and non-pharmacological approaches with or without dietary patterns, phytochemicals or exercise interventions are the practical strategies to combat MetS and associated diseases. However, designing and prescribing of optimal nutritional patterns and exercise regimens remains a big challenge to achieve the maximum beneficial effects. This thematic issue addressed the concerns and provided practical strategies to overcome the malady of MetS in the modern world.

Keywords: Inflammation, oxidative stress, physical activity, phytochemicals, obesity, MetS comorbidities.

Next »
[1]
Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Current hypertension reports 2018; 20(2): 12.
[3]
Costa FF, Rosário WR, Ribeiro Farias AC, et al. Metabolic syndrome and COVID-19: An update on the associated comorbidities and proposed therapies. Diabet Metabol Syn Clin Res Rev 2020; 14(5): 809-14.
[4]
Sahukari R, Punabaka J, Bhasha S, Ganjikunta VS, Ramudu SK, Kesireddy SR. Plant Compounds for the Treatment of Diabetes, a Metabolic Disorder: NF-κB as a Therapeutic Target. Curr Pharm Des 2020; 26(39): 4955-69.
[5]
Tung Y-T, Pan C-H. Chien.-W, Huang H-Y. Edible Mushrooms: Novel Medicinal Agents to Combat Metabolic Syndrome and Associated Diseases. Curr Pharm Des 2020; 26(39): 4970-81.
[6]
Su H, Liu D, Shao J, Li Y, Wang X, Gao Q. Aging Liver: Can Exercise be a Better Way to Delay the Process than Nutritional and Pharmacological Intervention? Focus on Lipid Metabolism. Curr Pharm Des 2020; 26(39): 4982-91.
[7]
Wang X, Kang J, Liu Q, Tong T, Quan H. Fighting Diabetes Mellitus: Pharmacological and Non-pharmacological Approaches. Curr Pharm Des 2020; 26(39): 4992-5001.
[8]
Li Q, Kuang X, Qi J. Correlates of Physical Activity of Children and Adolescents with Visual Impairments: A Systematic Review. Curr Pharm Des 2020; 26(39): 5002-11.
[9]
Shao T, Wang L, Chen H. Association Between Sedentary Behavior and Obesity in School-Age Children in China: A Systematic Review of Evidence. Curr Pharm Des 2020; 26(39): 5012-20.
[10]
Reddy D, Huang F, Wang S, Kumar R. Synergistic Antioxidant and Antibacterial Activity of Curcumin-C3 Encapsulated Chitosan Nanoparticles. Curr Pharm Des 2020; 26(39): 5021-9.

© 2024 Bentham Science Publishers | Privacy Policy